ArticleOncotarget2016
Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma.
Robert Nakayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this papertrialcites it
ArticleOncotarget2016
Robert Nakayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.